Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors

被引：107

作者：

Mease, PJ ^{[1
]}

机构：

[1] Seattle Rheumatol Associates, Seattle, WA 98104 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2002年 / 61卷 / 04期

关键词：

D O I：

10.1136/ard.61.4.298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

High levels of proinflammatory cytokines, including tumour necrosis factor (TNF), have been detected in psoriatic skin lesions and joints of patients with the inflammatory disease. Early results of treatment of psoriatic arthritis and psoriasis with TNF neutralising agents are encouraging, but whether these agents will be able to improve long term outcomes, such as disability, is not yet known.

引用

页码：298 / 304

页数：7

共 71 条

[1]

ABUSHAKRA M, 1995, J RHEUMATOL, V22, P241

[2]

ABUSHAKRA M, 1994, RHEUMATOL REV, V3, P1

[3]

ALONSO JCT, 1991, BRIT J RHEUMATOL, V30, P245

[4] TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset [J].